• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成素释放激素的发现及用于前列腺癌治疗的促黄体生成素释放激素类似物的研发。

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

作者信息

Schally Andrew V, Block Norman L, Rick Ferenc G

机构信息

Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education, Miami, Florida.

Department of Pathology, University of Miami Miller School of Medicine, Miami, Florida.

出版信息

Prostate. 2017 Jun;77(9):1036-1054. doi: 10.1002/pros.23360. Epub 2017 Apr 27.

DOI:10.1002/pros.23360
PMID:28449236
Abstract

The discovery, isolation, elucidation of structure, synthesis, and initial testing of the neuropeptide hypothalamic luteinizing hormone-releasing hormone (LHRH), which regulates reproduction, is briefly described. The design, synthesis, and experimental and clinical testing of agonistic analogs of LHRH is extensively reviewed focusing on the development of new methods for the treatment of prostate cancer. Subsequent development of antagonistic analogs of LHRH is then faithfully recounted with special emphasis on therapy of prostate cancer and BPH. The concepts of targeted therapy to peptide receptors on tumors are re-examined and the development of the cytotoxic analogs of LHRH and their status is reviewed. The endeavor to develop better therapies for prostate cancer, based on LHRH analogs, guided much of our work.

摘要

简要描述了调节生殖的神经肽下丘脑促黄体激素释放激素(LHRH)的发现、分离、结构阐明、合成及初步测试。重点围绕前列腺癌治疗新方法的开发,广泛综述了LHRH激动剂类似物的设计、合成以及实验和临床测试。接着如实叙述了LHRH拮抗剂类似物的后续开发情况,特别强调了其在前列腺癌和良性前列腺增生治疗方面的应用。重新审视了针对肿瘤上肽受体的靶向治疗概念,并综述了LHRH细胞毒性类似物的开发及其现状。基于LHRH类似物开发更好的前列腺癌治疗方法的努力,指导了我们的大部分工作。

相似文献

1
Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.促黄体生成素释放激素的发现及用于前列腺癌治疗的促黄体生成素释放激素类似物的研发。
Prostate. 2017 Jun;77(9):1036-1054. doi: 10.1002/pros.23360. Epub 2017 Apr 27.
2
Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.靶向细胞毒性促黄体生成素释放激素类似物AN-207对人实验性前列腺癌的抑制作用
Prostate. 2006 Feb 1;66(2):200-10. doi: 10.1002/pros.20335.
3
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.将细胞毒性促黄体生成素释放激素类似物靶向作用于乳腺癌、卵巢癌、子宫内膜癌和前列腺癌。
Biol Reprod. 2005 Nov;73(5):851-9. doi: 10.1095/biolreprod.105.043489. Epub 2005 Jul 20.
4
Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.促黄体生成素释放激素受体靶向药物治疗前列腺癌。
Expert Opin Investig Drugs. 2011 Jun;20(6):769-78. doi: 10.1517/13543784.2011.574611. Epub 2011 Mar 31.
5
AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.AEZS-108:一种针对 LHRH 受体阳性癌症的靶向细胞毒性 LHRH 类似物。
Expert Opin Investig Drugs. 2012 Jun;21(6):891-9. doi: 10.1517/13543784.2012.685128.
6
Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.促黄体生成素释放激素激动剂在前列腺癌治疗中的应用:对其发现、研发及治疗地位的综述
Clin Ther. 2006 Oct;28(10):1485-508. doi: 10.1016/j.clinthera.2006.10.018.
7
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).用靶向细胞毒黄体生成素释放激素类似物(AN-152)治疗多柔比星耐药的人葡萄膜黑色素瘤的实验治疗。
Eur J Pharm Sci. 2018 Oct 15;123:371-376. doi: 10.1016/j.ejps.2018.08.002. Epub 2018 Aug 2.
8
Bench-to-bedside development of agonists and antagonists of luteinizing hormone-releasing hormone for treatment of advanced prostate cancer.用于治疗晚期前列腺癌的促黄体生成素释放激素激动剂和拮抗剂从实验室到临床的研发
Urol Oncol. 2015 Jun;33(6):270-4. doi: 10.1016/j.urolonc.2014.11.006. Epub 2014 Dec 13.
9
Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs.糖基化促黄体生成素释放激素类似物的生物学特性及酶稳定性评估
AAPS J. 2015 Sep;17(5):1135-43. doi: 10.1208/s12248-015-9769-x. Epub 2015 May 9.
10
Agonists of luteinizing hormone-releasing hormone in prostate cancer.促黄体生成素释放激素激动剂在前列腺癌中的应用。
Expert Opin Pharmacother. 2013 Nov;14(16):2237-47. doi: 10.1517/14656566.2013.834328. Epub 2013 Aug 28.

引用本文的文献

1
A 50-year journey in the development of treatment for benign prostatic hyperplasia.良性前列腺增生治疗发展的50年历程。
NPJ Aging. 2025 May 23;11(1):41. doi: 10.1038/s41514-025-00231-2.
2
GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy.促性腺激素释放激素肽拮抗剂:化学与制剂的比较分析及其对临床安全性和有效性的影响
Pharmaceuticals (Basel). 2024 Dec 31;18(1):36. doi: 10.3390/ph18010036.
3
The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.
生长激素释放激素类似物的发展:癌症、再生医学和代谢紊乱领域的治疗进展
Rev Endocr Metab Disord. 2025 Jun;26(3):385-396. doi: 10.1007/s11154-024-09929-2. Epub 2024 Nov 26.
4
Growth hormone-releasing hormone and its analogues in health and disease.生长激素释放激素及其类似物在健康与疾病中的作用
Nat Rev Endocrinol. 2025 Mar;21(3):180-195. doi: 10.1038/s41574-024-01052-1. Epub 2024 Nov 13.
5
Growth hormone-releasing hormone and cancer.生长激素释放激素与癌症
Rev Endocr Metab Disord. 2024 Oct 18. doi: 10.1007/s11154-024-09919-4.
6
Impact of Androgen Deprivation Therapy on Cognitive Function of Elderly Men With Prostate Cancer.雄激素剥夺疗法对老年前列腺癌男性认知功能的影响。
Cureus. 2024 Sep 12;16(9):e69303. doi: 10.7759/cureus.69303. eCollection 2024 Sep.
7
Computational drug repurposing effort for identifying novel hits for the treatment of diseases such as endometriosis, uterine fibroids, and prostate cancer.用于识别治疗子宫内膜异位症、子宫肌瘤和前列腺癌等疾病新靶点的计算药物重新利用研究。
Turk J Chem. 2024 Jan 4;48(2):402-421. doi: 10.55730/1300-0527.3667. eCollection 2024.
8
Microfluidics-Based Technologies for the Assessment of Castration-Resistant Prostate Cancer.基于微流控技术的去势抵抗性前列腺癌评估方法
Cells. 2024 Mar 26;13(7):575. doi: 10.3390/cells13070575.
9
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.戈舍瑞林10.8毫克长效注射剂在中国局限性或局部晚期前列腺癌患者中的真实世界有效性和安全性
Cancer Biol Med. 2024 Feb 5;20(12):1047-59. doi: 10.20892/j.issn.2095-3941.2023.0335.
10
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.游离DNA基因组分析及其在晚期前列腺癌中的临床应用
Cancers (Basel). 2023 Dec 21;16(1):45. doi: 10.3390/cancers16010045.